GEORGE W. BURKE, MD
Radiology in Miami, FL

License number

Florida ME54585

Personal information

See more information about GEORGE W. BURKE at radaris.com

Name

Address

Phone

George Burke

4434 Parkway Commerce Blvd, Orlando, FL 32808

George Burke

4400 Pine Lake Dr, Saint Cloud, FL 34769

George Burke

5771 Stewart Ave, Port Orange, FL 32127

George Burke

601 SW 75Th Ter, Plantation, FL 33317

George Burke

5595 E Irlo Bronson Memorial H, Saint Cloud, FL 34771

Organization information

See more information about GEORGE W. BURKE at bizstanding.com

University Of Miami - George W Burke MD

1801 NW 9 Ave, Fl6, Miami, FL 33136

Categories:

General Surgeons

Phone:

(305) 355-5050 (Phone)

Professional information

See more information about GEORGE W. BURKE at trustoria.com

George William Burke, Miami FL

Specialties:

Surgery, Transplant Surgery

Work:

Highland Professional
1801 NW 9Th Ave, Miami, FL 33136 Jackson Memorial Hospital
1611 NW 12Th Ave, Miami, FL 33136

Education:

University of Massachusetts (1978) Surgery

George W Burke, Miami FL

Specialties:

Surgeon

Address:

1801 Nw 9Th Ave, Miami, FL 33136
1611 Nw 12Th Ave, Miami, FL 33136

Education:

University of Massachusetts, Medical School - Doctor of Medicine
University of MN Medical Center-Riverside Campus - Fellowship - Transplant Surgery
Beth Israel Deaconess Medical Center - Residency - Surgery

Board certifications:

American Board of Surgery Certification in Surgery

Assays, Methods And Kits For Predicting Renal Disease And Personalized Treatment Strategies

US Patent:

2013020, Aug 8, 2013

Filed:

Oct 14, 2011

Appl. No.:

13/879892

Inventors:

Alessia Fornoni - Coral Gables FL, US
George William Burke - Miami FL, US

International Classification:

G01N 33/50, A61K 39/395, A61K 38/17, C12Q 1/68, A61K 31/724

US Classification:

4241341, 435 29, 435 613, 506 10, 506 15, 4352871, 514 58, 4241331

Abstract:

Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the afore-mentioned disorders.